Cue Biopharma Cash from Financing (Quarterly) Analysis

Cue Biopharma Inc (CUE)

1.02 -0.01 (-0.97%) USD | NASDAQ | Nov 22, 16:00

1.05 +0.03 (+2.94%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
September 30, 2024	9.821M
June 30, 2024	-1.00M
March 31, 2024	2.354M
December 31, 2023	4.782M
September 30, 2023	4.589M
June 30, 2023	2.101M
March 31, 2023	0.388M
December 31, 2022	27.40M
September 30, 2022	-0.009M
June 30, 2022	11.11M
March 31, 2022	15.16M
December 31, 2021	7.382M
September 30, 2021	0.351M
June 30, 2021	10.67M
March 31, 2021	0.834M

Date	Value
December 31, 2020	0.2443M
September 30, 2020	15.01M
June 30, 2020	43.32M
March 31, 2020	0.036M
December 31, 2019	34.49M
September 30, 2019	12.29M
June 30, 2019	3.747M
March 31, 2019	0.257M
December 31, 2018	4.170M
September 30, 2018	0.012M
June 30, 2018	0.00
March 31, 2018	0.00
December 31, 2017	62.05M
September 30, 2017	-0.022M
June 30, 2017	-0.022M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-1.00M

Minimum

Jun 2024

43.32M

Maximum

Jun 2020

9.452M

Average

4.686M

Median

Cash from Financing (Quarterly) Benchmarks

Biomarin Pharmaceutical Inc	-499.12M
Arbutus Biopharma Corp	1.775M
GlycoMimetics Inc	0.00
FibroGen Inc	-0.127M
Cidara Therapeutics Inc	-0.182M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-7.527M
Cash from Investing (Quarterly)	0.098M
Free Cash Flow	-38.32M
Free Cash Flow Per Share (Quarterly)	-0.1469
Free Cash Flow to Equity (Quarterly)	-6.568M
Free Cash Flow Yield	-75.88%